Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

New laser zaps away prostate problems in minutes

NCT ID NCT02683980

Symptom relief Sponsor: Boston Scientific Corporation Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tested a special laser to treat an enlarged prostate (BPH) in 20 men who needed surgery. The laser was used to vaporize extra prostate tissue, and the men were followed for 3 months to see how well it worked and if there were side effects. The goal was to find out if this laser is a safe and effective way to ease symptoms like trouble urinating.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

20 people

The number who actually took part.

Started

Feb 2016

Finished

Nov 2017

Lead sponsor

A company

The lead sponsor is a pharmaceutical, biotech, or medical-device company.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Male participants only

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Subject will be older than 18 years of age * Subject was diagnosed with enlarged prostate of ≥ 30 gr volume * Subject is a candidate for surgery treatment * Subject is willing and has signed the Informed Consent Form * AUA score ≥ 12 * Qmax \<15 mL/s Exclusion Criteria: * Need to perform concomitant procedure, other than prostate vaporization * PVR \> 300 mL * Current Urine retention and Pdet \<40 cm H20 * Documented or suspected prostate cancer and / or bladder cancer * Neurogenic bladder disorder / neurogenic voiding dysfunction * Urethral strictures * Previous prostatic, bladder neck, or urethral surgery * Known history of spinal cord injury * Urogenital trauma * Bladder neck stricture * Evidence of urinary tract infection * History of chronic prostatitis

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Treatment of benign prostatic hyperplasia are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

benign prostatic hyperplasia

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Treatment of benign prostatic hyperplasia

Contacts and locations

Locations

  • New York Methodist Hospital

    New York, New York, 11215, United States